TWI340167B - Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof - Google Patents

Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof

Info

Publication number: TWI340167B
Authority: TW; Taiwan
Prior art keywords: antibiotic; factors; compositions; pharmaceutically acceptable; acceptable salts
Prior art date: 2003-07-18

Application number

TW093121124A

Other languages

Chinese (zh)

Other versions

TW200510541A (en

Inventor

Ameriga Lazzarini

Luciano Gastaldo

Gianpaolo Candiani

Ismaela Ciciliato

Daniele Losi

Flavia Marinelli

Enrico Selva

Franco Parenti

Original Assignee

Sentinella Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-18

Filing date

2004-07-15

Publication date

2011-04-11

2004-07-15 Application filed by Sentinella Pharmaceuticals Inc filed Critical Sentinella Pharmaceuticals Inc

2005-03-16 Publication of TW200510541A publication Critical patent/TW200510541A/en

2011-04-11 Application granted granted Critical

2011-04-11 Publication of TWI340167B publication Critical patent/TWI340167B/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Mycology (AREA)
Polymers & Plastics (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Food Science & Technology (AREA)
Animal Husbandry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW093121124A 2003-07-18 2004-07-15 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof TWI340167B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03016306		2003-07-18

Publications (2)

Publication Number	Publication Date
TW200510541A TW200510541A (en)	2005-03-16
TWI340167B true TWI340167B (en)	2011-04-11

Family

ID=34130026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW093121124A TWI340167B (en)	2003-07-18	2004-07-15	Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof

Country Status (12)

Country	Link
US (1)	US7307057B2 (en)
EP (1)	EP1646646B1 (en)
JP (1)	JP4163737B2 (en)
AR (1)	AR046809A1 (en)
AT (1)	ATE356143T1 (en)
BR (1)	BRPI0412591A (en)
CA (1)	CA2529124C (en)
DE (1)	DE602004005203T2 (en)
ES (1)	ES2281808T3 (en)
MX (1)	MXPA06000691A (en)
TW (1)	TWI340167B (en)
WO (1)	WO2005014628A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7319088B2 (en)	2003-07-18	2008-01-15	Vicuron Pharmaceuticals Inc.	Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
US7351687B2 (en)	2003-07-18	2008-04-01	Vicuron Pharmaceuticals, Inc.	Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
RS52513B (en) *	2005-01-12	2013-04-30	Sentinella Pharmaceuticals Inc. ("Sentinella")	Antibiotic 107891, its factors, pharmaceutically acceptable salts and compositions, and use thereof
WO2006075988A1 (en)	2005-01-12	2006-07-20	Vicuron Pharmaceuticals Inc.	Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
GB0600928D0 (en)	2006-01-17	2006-02-22	Novacta Biosystems Ltd	Improvements relating to lantibiotics
GB0714029D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	The use of type-B lantibiotic-based compounds having antimicrobial activity
US8609367B2 (en)	2007-08-03	2013-12-17	Sentinella Pharmaceuticals, Inc.	Genes and proteins for the biosynthesis of the lantibiotic 107891
KR20110119699A (en)	2009-01-14	2011-11-02	노박타 바이오시스템스 리미티드	Deoxyactagardine derivatives
EP2393829A1 (en)	2009-02-04	2011-12-14	Novacta Biosystems Limited	Actagardine derivatives
GB201001688D0 (en)	2010-02-02	2010-03-17	Novacta Biosystems Ltd	Compounds
GB201013513D0 (en)	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Formulations
US9975930B2 (en)	2012-11-30	2018-05-22	Naicons S.R.L.	Lantibiotic derivatives and process for their preparation
US11174288B2 (en)	2016-12-06	2021-11-16	Northeastern University	Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
SG11201914046WA (en)	2017-07-07	2020-01-30	Epicentrx Inc	Compositions for parenteral administration of therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59198982A (en)	1983-04-28	1984-11-10	Meiji Seika Kaisha Ltd	Novel antibiotic substance sf-2240 and its preparation
EP0592835A3 (en)	1992-09-23	1995-03-15	Bristol Myers Squibb Co	BU-4803T Antibiotics.
US6551591B1 (en) *	2001-09-07	2003-04-22	Essential Therapeutics, Inc.	Antibiotics from microbispora

2004
- 2004-07-12 MX MXPA06000691A patent/MXPA06000691A/en active IP Right Grant
- 2004-07-12 JP JP2006520724A patent/JP4163737B2/en not_active Expired - Fee Related
- 2004-07-12 US US10/521,336 patent/US7307057B2/en not_active Expired - Lifetime
- 2004-07-12 ES ES04740916T patent/ES2281808T3/en not_active Expired - Lifetime
- 2004-07-12 AT AT04740916T patent/ATE356143T1/en not_active IP Right Cessation
- 2004-07-12 WO PCT/EP2004/007658 patent/WO2005014628A1/en active IP Right Grant
- 2004-07-12 EP EP04740916A patent/EP1646646B1/en not_active Expired - Lifetime
- 2004-07-12 BR BRPI0412591-6A patent/BRPI0412591A/en not_active IP Right Cessation
- 2004-07-12 DE DE602004005203T patent/DE602004005203T2/en not_active Expired - Lifetime
- 2004-07-12 CA CA2529124A patent/CA2529124C/en not_active Expired - Fee Related
- 2004-07-15 TW TW093121124A patent/TWI340167B/en not_active IP Right Cessation
- 2004-07-19 AR ARP040102548A patent/AR046809A1/en active IP Right Grant

Also Published As

Publication number	Publication date
US7307057B2 (en)	2007-12-11
EP1646646A1 (en)	2006-04-19
JP2007525479A (en)	2007-09-06
DE602004005203D1 (en)	2007-04-19
EP1646646B1 (en)	2007-03-07
MXPA06000691A (en)	2006-04-11
JP4163737B2 (en)	2008-10-08
AR046809A1 (en)	2005-12-28
DE602004005203T2 (en)	2007-11-22
CA2529124A1 (en)	2005-02-17
US20060183673A1 (en)	2006-08-17
BRPI0412591A (en)	2006-09-19
ES2281808T3 (en)	2007-10-01
TW200510541A (en)	2005-03-16
CA2529124C (en)	2011-02-08
ATE356143T1 (en)	2007-03-15
WO2005014628A1 (en)	2005-02-17

Similar Documents

Publication	Publication Date	Title
IL175953A (en)	2015-09-24	3-cycloalkylaminopyrrolidine derivatives, pharmaceutically acceptable salts thereof and compositions comprising the same
IL176005A0 (en)	2006-10-05	2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
IL178079A (en)	2015-04-30	Phenyl 1- phenyl-1,2,3,4-tetrahydro-ß-carboline-2-carboxylate derivatives and pharmaceutical compositions comprising the same
HK1090368A1 (en)	2006-12-22	2,3,6-trisubstituted-4-pyrimidone derivatives
HK1080482A1 (en)	2006-04-28	Novel thiophenylglycoside derivatives, methods forproduction thereof, medicaments comprising said c ompounds and use thereof
AU2003243354A8 (en)	2003-12-19	Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
AU2003289440A1 (en)	2004-07-22	Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
AU2003289641A1 (en)	2004-06-23	The novel coumarin-amide derivatives and its preparation, said drug composition and its use
IL174479A (en)	2015-08-31	Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof
HK1081954A1 (en)	2006-05-26	Novel 1,4-diazabicycloalkane derivatives, their preparation and use
TWI340167B (en)	2011-04-11	Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
HUP0500871A3 (en)	2006-11-28	5-aryltetrazole compounds, compositions thereof and their use
ZA200705495B (en)	2008-12-31	Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
PL394604A1 (en)	2011-07-18	Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
AU2003292422A1 (en)	2004-07-14	Oxazolidinone derivatives and their use as antibacterial agents
EP1542696A4 (en)	2006-08-02	Oxazolidinone derivatives as antimicrobials
IL181216A0 (en)	2007-07-04	3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
IL154240A0 (en)	2003-07-31	4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
AU2003292426A1 (en)	2004-07-14	Oxazolidinone derivatives as antibacterial agents
EP1628668A4 (en)	2010-03-17	1,1-disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibito rs
PL374761A1 (en)	2005-10-31	N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
AU2002368487A1 (en)	2004-07-14	Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists
IL184376A0 (en)	2007-10-31	Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
ZA200705494B (en)	2008-11-26	Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
HK1062274A1 (en)	2004-10-29	Medicinal composition

Legal Events

Date	Code	Title	Description
2016-01-11	MM4A	Annulment or lapse of patent due to non-payment of fees